Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


25.09.2017

4 Hepatology
7 J Gastroenterol Hepatol
1 J Hepatol
1 N Engl J Med
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Hepatology

  1. WYLES D, Poordad F, Wang S, Alric L, et al
    Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial.
    Hepatology. 2017 Sep 19. doi: 10.1002/hep.29541.
    PubMed     Text format     Abstract available

  2. LAI JC, Covinsky KE, Dodge JL, Boscardin WJ, et al
    Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Hepatology. 2017;66:564-574.
    PubMed     Text format     Abstract available

  3. WAN Y, Meng F, Wu N, Zhou T, et al
    Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29138.
    PubMed     Text format     Abstract available

  4. MARONI L, Hohenester SD, van de Graaf SF, Tolenaars D, et al
    Knockout of the Primary Sclerosing Cholangitis-Risk Gene Fut2 Causes Liver Disease in Mice.
    Hepatology. 2017 Jan 5. doi: 10.1002/hep.29029.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  5. SOOD A, Khurana MS, Mahajan R, Midha V, et al
    Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2017;32:446-450.
    PubMed     Text format     Abstract available

  6. JEON SR, Byeon JS, Jang HJ, Park SJ, et al
    Clinical outcome after enteroscopy for small bowel angioectasia bleeding: A Korean Associateion for the Study of Intestinal Disease (KASID) multiceter study.
    J Gastroenterol Hepatol. 2017;32:388-394.
    PubMed     Text format     Abstract available

  7. PARK TY, Lee SK, Nam K, Oh D, et al
    Spontaneous hemobilia after liver transplantation: frequency, risk factors, and outcome of endoscopic management.
    J Gastroenterol Hepatol. 2016 Jul 23. doi: 10.1111/jgh.13497.
    PubMed     Text format     Abstract available

  8. LIU Z, Wei X, Chen T, Huang C, et al
    Characterization of fibrosis changes in chronic hepatitis C patients after virological cure: A systematic review with meta-analysis.
    J Gastroenterol Hepatol. 2017;32:548-557.
    PubMed     Text format     Abstract available

  9. XU Q, Sheng L, Bao H, Chen X, et al
    Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis.
    J Gastroenterol Hepatol. 2017;32:639-644.
    PubMed     Text format     Abstract available

  10. TADA T, Kumada T, Toyoda H, Kiriyama S, et al
    Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.
    J Gastroenterol Hepatol. 2017;32:687-694.
    PubMed     Text format     Abstract available

  11. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
    Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.
    J Gastroenterol Hepatol. 2017 Sep 15. doi: 10.1111/jgh.13989.
    PubMed     Text format     Abstract available


    J Hepatol

  12. THABUT D, Pauwels A, Carbonell N, Remy AJ, et al
    Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results.
    J Hepatol. 2017 Sep 13. pii: S0168-8278(17)32281.
    PubMed     Text format     Abstract available


    N Engl J Med

  13. TAPPER EB, Lok AS
    Use of Liver Imaging and Biopsy in Clinical Practice.
    N Engl J Med. 2017;377:756-768.
    PubMed     Text format    


    PLoS One

  14. DOLD L, Luda C, Schwarze-Zander C, Boesecke C, et al
    Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
    PLoS One. 2017;12:e0178685.
    PubMed     Text format     Abstract available

  15. KRAUSKOPF J, de Kok TM, Schomaker SJ, Gosink M, et al
    Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.
    PLoS One. 2017;12:e0177928.
    PubMed     Text format     Abstract available

  16. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Text format     Abstract available

  17. MOQUEET N, Kanagaratham C, Gill MJ, Hull M, et al
    A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
    PLoS One. 2017;12:e0176282.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: